Synthetic data is being treated less like a niche privacy tool and more like a scaling lever for model training and regulated workflows. This brief spans new scaling claims (SynthLLM), a 2020–2025 survey of LLM-based generation, and sector guidance for finance, healthcare, and policy leaders.
SynthLLM: Breaking the AI “data wall” with scalable synthetic data
Microsoft Research introduced SynthLLM, a framework aimed at generating synthetic data at scale to address training data shortages for large language models. The article argues that synthetic data can follow similar scaling laws to natural data, positioning generation as a repeatable input to continued capability gains. The pitch is practical: if scaling behavior holds, teams can trade expensive collection/labeling cycles for controlled generation and verification loops.
- For LLM builders, “scaling laws” language reframes synthetic data from augmentation to a primary supply chain.
- For privacy leads, it strengthens the case for synthetic-first pipelines in sensitive domains (e.g., healthcare) where raw data access is constrained.
- For founders, it raises competitive pressure: data moats may erode if high-quality synthetic can substitute for proprietary corpora.
Synthetic Data Generation Using Large Language Models
This arXiv survey reviews how LLMs are used to generate synthetic data for text and code tasks, covering approaches such as prompt engineering and iterative refinement. It synthesizes findings from studies between 2020 and 2025, focusing on effects on performance, diversity, and efficiency. For practitioners, the value is less “new method” and more a map of what has been tried—and where failure modes (e.g., narrow diversity or brittle prompts) show up.
- Data teams can use the survey to standardize evaluation: utility, diversity, and efficiency trade-offs are recurring themes.
- Security/compliance teams get a clearer view of risk surfaces when LLMs are used as generators rather than predictors.
Synthetic Data in Investment Management
CFA Institute’s report targets financial workflows where data scarcity, imbalance, and privacy constraints are routine. It covers both traditional and generative approaches and includes a case study on fine-tuning LLMs. The throughline is governance: synthetic data is positioned as a way to enable experimentation while maintaining privacy and meeting audit expectations.
- Investment firms can pilot new models without expanding access to sensitive client or trading datasets.
- Vendors should expect buyers to ask for fidelity/utility evidence, not just “privacy-preserving” claims.
Impact of synthetic data generation for high-dimensional cross-sectional medical data: a simulation study
In JAMIA, researchers evaluated seven generative models across 12 medical datasets to test how adding adjunct variables impacts fidelity, utility, and privacy. The study reports that these metrics can be preserved even as dimensionality increases. For healthcare data-sharing platforms, this supports a strategy of broader feature inclusion without automatically sacrificing privacy posture.
- Healthcare teams can consider higher-dimensional synthetic releases while still tracking fidelity/utility/privacy jointly.
- Platform operators can use results to justify synthetic cohorts for exploratory analysis and method development.
Synthetic Data: The New Data Frontier
The World Economic Forum published a strategic brief on adopting synthetic data while maintaining accuracy, equity, and privacy standards. It highlights uses in testing, personalized AI, healthcare, and e-commerce, and frames synthetic data as a leadership and policy concern—not just a technical tool. Expect this to influence procurement language and “responsible AI” checklists in global organizations.
- Compliance teams will see more external pressure to document equity and privacy considerations alongside utility.
- Founders selling synthetic tooling should align messaging with standards language (accuracy, equity, privacy), not only speed.